http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1125298-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_620ecb9324409347c27e96b6071503ee |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-86 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-52 |
| filingDate | 1978-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1982-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d89846df8128952f5e942b76ec537b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bb9b193ff512254268a38ea11f19003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08572600762c2dc44fc238a6d51a0d71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12c3656fa92bee58ac11f1e975e6f4f6 |
| publicationDate | 1982-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1125298-A |
| titleOfInvention | Process for the preparation of heterocyclic compounds |
| abstract | PROCESS OF PRODUCING HETEROCYCLIC COMPOUNDS ABSTRACT Process of producing heterocyclic compounds shown by the formula wherein Het represents a 5-membered or 6-membered heterocyclic group which may have substituent(s); z represents sulfur atom or oxygen atom; X represents oxygen atom or the unsubstituted or substituted imino group shown by N-R1 (wherein R1 is hydrogen atom a lower alkyl group, a cyano group, an unsubstituted or alkyl substituted carbamoyl group, an unsubstituted or lower alkyl sub-stituted thiocarbamoyl group, or a lower alkanoylamino group); Y represents hydrogen atom, a lower alkyl group which may have sub-stituent(s), a cycloalkyl group of 3-6 carbon atoms, a lower alkenyl group, a lower alkynyl group, an aryl group which may have substituent(s), an aralkyl group which may have substltuent(s), a hydroxyl group, a cyano group, a carbamoyl group, an amidino group, an alkanoyl group which may have been substituted by halo-gen atom(s), an alkanoylamino group, an arylcarbonylamino group, an alkylamino group, an arylamino group, an arylsulfamoyl group, a lower alkoxycarbamoyl group, or an oxamoylamino group; and m and n represent an integer of 1-3; when X is N-R1, said X and Y may combine with each other to form a 5-membered or 6-membered heterocyclic ring containing 2-3 nitrogen atoms which may have substituent(s), and the pharmacologically acceptable acid addition salts thereof. The compounds of this invention are useful as gastric acid secretion inhibitors. |
| priorityDate | 1977-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 282.